SEC Form 4 · accession 0001209191-15-003530
Microbot Medical Inc. · MBOT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin M McGlynn
Officer — President & CEO · Director
Period of report
Jan 8, 2015
Accepted (ET)
Jan 9, 2015 · 6:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000883975
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 8, 2015 | A | 1,255,500 | $0.00 | A | 2,274,391 | D | |
| Common StockF3,F4 | Jan 8, 2015 | A | 418,500 | $0.00 | A | 2,692,891 | D | |
| Common StockF5 | holding | — | — | — | 22,921 | I | By 401(k) plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock units, with 1/3 vesting on each of January 8, 2016, January 8, 2017, and January 8, 2018.
- F2Includes (1) 525,000 restricted stock units, with 175,000 of these vesting on each of June 14, 2015, June 14, 2016, and June 14, 2017; (2) 135,333 restricted stock units vesting on January 27, 2015, and (3) 1,255,500 restricted stock units, with 418,500 of these vesting on each of January 8, 2016, January 8, 2017 and January 8, 2018.
- F3Restricted stock units, with performance based vesting set by the issuer's Board of Directors and tied to the timely and successful conduct and completion of the issuer's Phase II clinical studies in dry AMD and spinal cord injury.
- F4Includes (1) 525,000 restricted stock units, with 175,000 of these vesting on each of June 14, 2015, June 14, 2016, and June 14, 2017; (2) 135,333 restricted stock units vesting on January 27, 2015; (3) 1,255,500 restricted stock units, with 418,500 of these vesting on each of January 8, 2016, January 8, 2017 and January 8, 2018; and (4) 418,500 restricted stock units with performance based vesting.
- F5Shares held in 401(k) account in accordance with issuer's employer-match policies.